ACADIA Pharmaceuticals Inc. - Common Stock (ACAD) — AI analysis & news
ACADIA Pharmaceuticals Inc. - Common Stock (ACAD) stock: 12 recent news items, slightly negative aggregate sentiment, AI analysis and market context on…
Current sentiment read
Across the last 12 indexed ACAD stories, aggregate finance-aware sentiment is slightly negative (-0.13 on a -1 to +1 scale).
Latest ACAD news
- Acadia Pharmaceuticals stock hits 52-week low at 19.01 USD By Investing.com - Investing.com UK · Investing.com UK
- Pacira Pharmaceuticals stock hits 52-week high at 36.32 USD By Investing.com - Investing.com UK · Investing.com UK
- RBC Capital reiterates Acadia Pharmaceuticals stock rating on patent developments - Investing.com India · Investing.com India
- Why is ACADIA Pharmaceuticals stock climbing today? - Investing.com · Investing.com
- Why is ACADIA Pharmaceuticals stock climbing today? By Investing.com - Investing.com India · Investing.com India
- Acadia Pharmaceuticals stock hits 52-week low at $19.66 By Investing.com - Investing.com India · Investing.com India
- Needham cuts Acadia Pharmaceuticals stock price target on trial results - Investing.com India · Investing.com India
- Citizens cuts Acadia Pharmaceuticals stock price target on trial miss By Investing.com - Investing.com India · Investing.com India
- Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO · Bloomberg
- BMO cuts Acadia Pharmaceuticals stock price target on trial miss By Investing.com - Investing.com UK · Investing.com UK
- Why is ACADIA Pharmaceuticals stock tumbling today? - Investing.com · Investing.com
- Why is ACADIA Pharmaceuticals stock tumbling today? By Investing.com - Investing.com UK · Investing.com UK
FAQ
What is the current sentiment for ACAD stock?
Aggregate finance-aware sentiment across the last 12 indexed ACAD news stories is slightly negative (-0.13 on a -1 to +1 scale).